Get In Touch
606 Tower A Plot, I-Thum Tower, Sector 62, Noida, Uttar Pradesh, IN
Ph: +91 8383.033.985
Work Inquiries
Ph: +91 8383.033.985

India: Patent Highlights of 2014


The yr 2014 turned a lot of our established patent rules on their head and in contrast to earlier years some astounding judgments got here from Excessive Courts across the nation not simply from Delhi. At first of the yr, we had Choose Ramasubramaniam, defining numerous provisions of the Indian Patents Act and laying down rules on how a patent trial must be carried out and what proof is required for a patentee in a Patent infringement go well with to determine infringement of a patent. Not many individuals realized, even within the authorized fraternity, that this was a judgment after full trial in a go well with for patent infringement. The Madras judgment was adopted by the choice within the writ petition filed by Teijin Ltd within the Mumbai Excessive Courtroom which handled renewals in respect of patents which endorsed the facility of the Controller of Patents to treatment a clerical error dedicated throughout prosecution beneath part 129 and 137 of the Act. From Mumbai, the scene shifted again to Chennai. Within the NTT DoCoMo Inc. case the place Justice Raja echoed the rules laid down within the Teijin case. In April 2014, Justice Manmohan Singh of the Delhi Excessive Courtroom had an event to determine upon the maintainability of a go well with beneath the Patents Act when there have been alleged discrepancies within the Recordal of an unique license settlement in favour of the plaintiff. Justice Manmohan Singh refused to dismiss the go well with with out completion of the Recordal proceedings. In an extra judgment, thereafter, in an enchantment filed by 3M towards Venus Security Justice Manmohan Singh whereas refusing to grant an injunction to the plaintiff held that “A slight trivial or infinitesimal variation from a pre-existing invention wouldn’t qualify to be a sound invention”. As soon as once more in Sandeep Jaidka vs. Mukesh Mittal, Justice Manmohan Singh refused to grant an interim injunction in respect of patent infringement the place admittedly the plaintiff was not working the patent.

June noticed the Supreme Courtroom deciding as soon as and for all in Aloys Wobben vs. Yogesh Mehra {that a} defendant in a patent infringement go well with may solely use one of many treatments obtainable beneath the Patents Act to assault the validity of a patent. These treatments embody submitting a submit grant opposition beneath Part 25, a revocation motion beneath Part 64 and a counter declare for revocation in a go well with for infringement. Nonetheless, inadvertently, the Supreme Courtroom additionally decreased the helpful lifetime of a granted patent by one complete yr when it said that an infringement motion can’t be initiated within the first yr, when a patent was nonetheless open to problem beneath a submit grant opposition. In July, the scene moved again to Mumbai the place within the Bayer Company case, Justices Shah and Sanklecha upheld the Controller of Patents order and the IPAB order within the Bayer vs. Natco Saga for the obligatory license in respect of the most cancers drug popularly often known as Nexavar. An necessary aspect discovering was that it was not obligatory for establishing working in India {that a} patented drug needed to be manufactured in India. Bayer appealed from this judgment to the Supreme Courtroom however on the finish of the yr the obligatory license granted in favour of Natco was not disturbed. It seems that what swayed every of the adjudicators towards Bayer was Bayer’s refusal to offer particulars of R&D prices incurred that have been requested for by the Courts and its apathy in direction of promoting the product in India.

Some necessary points in qualifying who may be thought-about as an knowledgeable in main proof in patent fits was mentioned in two instances within the yr. Within the first case, Vringo vs. IndiaMart, Justice Shaliof the Delhi Excessive Courtroom identified {that a} witness who shouldn’t be an Indian Patent Agent can’t be thought-about as an knowledgeable to present an opinion whether or not an Indian Patent is infringed in India. Additional, a self favouring admission by the plaintiff can’t be thought-about related beneath Part 21 of the Proof Act. To be thought-about as an knowledgeable, Justice Shali suggests two situations. Firstly, the knowledgeable ought to have no less than a fundamental diploma within the subject and as well as ought to have some analysis work carried out by him in that space. A generalist ‘can’t be thought-about as an knowledgeable in that subject’. Additional, Justice Shali equated the {qualifications} of an knowledgeable in a subject to be commensurate with the {qualifications} for a scientific advisor as offered in Rule 103 of the Patents Rule.The second case on the topic was determined in Calcutta, later, within the yr in November;Justice Mukerji in Rajesh Kumar Banka vs. Union of India gave an opinion on the qualities of an knowledgeable witness. The knowledgeable witness on this case, referring to a plastic sealing machine, was a B.Tech in polymer expertise. Justice Mukerji got here to the conclusion that in these issues Part 45 of the Indian Proof Act pointed in the precise route and such an individual must be particularly expert within the subject and that such a witness’s testimony is all the time open to cross examination. There was an extra ratio {that a} Courtroom shouldn’t flip into an knowledgeable during which it has no competence. Within the case of Salzer Electronics restricted vs. SG controls, the Appellate Bench of the Madras Excessive Courtroom was required to take care of the decrease Courts order refusing an interim injunction.The bench whereas setting apart the decrease Courts order said that an order dismissing an interim injunction should be a reasoned order with out expressing any opinion on deserves and should take note of all the small print and info. The order ought to give ample causes for refusing an interim injunction.

As in earlier years, pharmaceutical patents have been additionally the topic of patent disputes. There was a judgement in Novartis vs. Ranbaxy in respect of Vida Gliptin during which Ranbaxy was briefly restrained. The Single Judges Order was appealed towards and the enchantment bench’s order confirmed the interim injunction. Merck Serono succeeded in overturning the abandonment order of the Controller of Patents and within the enchantment filed by Bristol-Myers vs. Mylan Labs in respect of the drug Atazanavir, Mylan Labs was permitted to export the drug to Venezuela however was requested to take care of accounts and deposit 5% of the income it obtained in Courtroom until the disposal of the go well with. On the finish of the yr, within the Gharda Chemical substances Restricted case, the Bombay Excessive Courtroom dropped a bomb shell when it said that staff’ innovations don’t robotically belong to the employer.

Supply by R Dewan

Post a comment

Your email address will not be published. Required fields are marked *